MedPath

The antihypertensive efficacy of Azilsartan on Nocturnalblood pressure by automated sphygmomanometer

Not Applicable
Recruiting
Conditions
hypertension
Registration Number
JPRN-UMIN000011403
Lead Sponsor
Department of cardiology Kitasato institute hospital Kitasato University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

A history of myocardial infarction within 1 week A history of cerebrovascular disorder within 3 months Serum Cr>2.0 mg/dL history of hyperergia to Azilsartan and Olmesartan or similar compounds Patients with pregnancy or with the possibility of pregnancy Patients started taking Olmesartan within 4 weeks Patients who changed the antihypertensive drugs most recently.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
variation of nocturnal blood pressure
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath